Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
headphones
Project Oncology®

Project Oncology®

ReachMD

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
bookmark
Share icon

All episodes

Best episodes

Top 10 Project Oncology® Episodes

Goodpods has curated a list of the 10 best Project Oncology® episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to Project Oncology® for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite Project Oncology® episode by adding your comments to the episode page.

Project Oncology® - Addressing Unmet Needs in HER2-Low Breast Cancer Care
play

02/17/22 • 0 min

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Maryam Lustberg, MD, MPH

Amid the evolving treatment landscape for HER2-low breast cancer, many therapeutic challenges and limitations remain, resulting in unmet needs for our patients. Fortunately, developments in the therapeutic landscape can help address those unmet needs, and joining Dr. Charles Turck to share what’s on the horizon is Dr. Maryam Lustberg.

bookmark
plus icon
share episode
Host: Jennifer Caudle, DO
Guest: Lindsey Roeker, MD

Dr. Jennifer Caudle is joined by Dr. Lindsey Roeker, a hematologist and medical oncologist at Memorial Sloan Kettering Cancer Center, to discuss evolving outcome measures and critical diagnostic biomarkers in patients with chronic lymphocytic leukemia.

bookmark
plus icon
share episode
Guest: Fred R. Hirsch, MD, PhD

Dr. Fred R. Hirsch, Executive Director at the Center for Thoracic Oncology in the Tisch Cancer Institute at Mount Sinai and Associate Director of Biomarker Discovery for TCI discusses key studies presented at the 2021 American Society of Clinical Oncology meeting surrounding updates in lung cancer research.

bookmark
plus icon
share episode
Host: Samilia Obeng-Gyasi, MD, MPH

How do surgical delays play a role in breast cancer outcomes? Dr. Samilia Obeng-Gyasi, an Assistant Professor of Surgery at Ohio State University, shares insight from her presentation at the 2021 American Society of Clinical Oncology Annual Meeting.

bookmark
plus icon
share episode
Guest: David R. Gandara, MD

Dr. David R. Gandara walks us through some of the most recent clinical trial data on non-small cell lung cancer from the 2021 American Society of Clinical Oncology Annual Meeting.

bookmark
plus icon
share episode
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Lincoln Nadauld, MD, PhD

Current cancer screening methods like mammograms, colonoscopies, and CT scans are all effective in detecting cancers, but they don’t always detect cancers as early as we’d like them to, resulting in missed and delayed diagnoses. Could new technology like multicancer early detection (MCED) be the answer to addressing current unmet needs in cancer screening? Find out with Dr. Charles Turck and Dr. Lincoln Nadauld, an oncologist and the Vice President and Chief of Precision Health and Academics at Intermountain Healthcare.

bookmark
plus icon
share episode
Guest: Michael R. Shafique, MD

Once we identify RET fusion abnormalities in patients with non-small cell lung cancer, what targeted therapies are available to us? Tune in to hear Dr. Michael Shafique, Assistant Professor of Thoracic Oncology at the Moffitt Cancer Center, share a brief overview of targeted therapies for patients with RET-rearranged non-small cell lung cancer.

bookmark
plus icon
share episode
Guest: Michael R. Shafique, MD

Here to give us a look at the unique genetic characteristics and prognostic implications for male and female patients with non-small cell lung cancer who harbor the RET fusion gene is Dr. Michael Shafique, Assistant Professor of Thoracic Oncology at the Moffitt Cancer Center in Tampa, Florida.

bookmark
plus icon
share episode
Guest: D. Ross Camidge, MD, PhD

What are some of the clinical considerations for RET-rearranged non-small cell lung cancer? Dr. Ross Camidge, Director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado, briefly discusses the guidelines and benefits of therapy recommended for non-small cell lung cancer by the National Comprehensive Cancer Network.

bookmark
plus icon
share episode
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Ehab L. Atallah, MD

New longer-term outcome data for chronic lymphocytic leukemia (CLL) has recently emerged with some interesting results. To dive into the key findings of these trials and other current CLL treatments available, Dr. Charles Turck is joined by Dr. Ehan Atallah, Professor of Medicine and the Section Head of Hematological Malignancies at the Medical College of Wisconsin Division of Hematology and Oncology.

bookmark
plus icon
share episode

Show more best episodes

Toggle view more icon

FAQ

How many episodes does Project Oncology® have?

Project Oncology® currently has 301 episodes available.

What topics does Project Oncology® cover?

The podcast is about Health & Fitness, Medicine, Podcasts and Science.

What is the most popular episode on Project Oncology®?

The episode title 'Pediatric Oncofertility: Key Considerations & Procedures' is the most popular.

How often are episodes of Project Oncology® released?

Episodes of Project Oncology® are typically released every 2 days.

When was the first episode of Project Oncology®?

The first episode of Project Oncology® was released on Aug 31, 2015.

Show more FAQ

Toggle view more icon

Comments